General Information
-
DRAMP ID
- DRAMP29198
-
Peptide Name
- SARS-CoV-2-S(1168–1203)-GSGSGC
-
Source
- Synthetic construct
-
Family
- Belongs to the betacoronaviruses spike protein family.
-
Gene
- S
-
Sequence
- DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSGC
-
Sequence Length
- 42
-
UniProt Entry
- P0DTC2
-
Protein Existence
- Protein level
Activity Information
-
Biological Activity
- Antimicrobial, Antiviral(SARS-CoV-2)
-
Target Organism
-
- [Ref.33082259]Virus:
- SARS-CoV-2:ihibition of cell-cell fusion in 293T cells(IC50=10±8 nM,IC90=98±57 nM),inhibition of infection in Vero E6 cells(IC50~ 6 nM);
- SARS-CoV-2_D614G:ihibition of cell-cell fusion in 293T cells(IC50=8±4 nM,IC90=96±50 nM);
- SARS-CoV-2_S943P:ihibition of cell-cell fusion in 293T cells(IC50=6±4 nM,IC90=75±42 nM);
- SARS-CoV-2_S247R:ihibition of cell-cell fusion in 293T cells(IC50=9±7 nM,IC90=78±59 nM);
- MERS-CoV:ihibition of cell-cell fusion in 293T cells(IC50=35±10 nM,IC90>1000 nM),inhibition of infection in Vero E6 cells(IC50~ 3 nM);
- SARS-CoV-1:ihibition of cell-cell fusion in 293T cells(IC50=7±5 nM,IC90=43±6 nM).
-
Hemolytic Activity
-
- No hemolysis information or data found in the reference(s) presented in this entry
-
Cytotoxicity
-
- [Ref.33082259]Human embryonic kidney HEK293T cells:18% Cytotoxicity at 10 µM;Vero E6 cells:12% Cytotoxicity at 1 µM,30% Cytotoxicity at 10 µM;Human airway epithelial cells:25% Cytotoxicity at 1 µM.
-
Binding Target
- liposomes
Structure Information
-
Linear/Cyclic
- Linear
-
N-terminal Modification
- Free
-
C-terminal Modification
- Free
-
Nonterminal Modifications and Unusual Amino Acids
- None
-
Stereochemistry
- L
-
Structure
- Not found
-
Structure Description
- Not found
-
Helical Wheel Diagram
-
PDB ID
- None
-
Predicted Structure
- There is no predicted structure for DRAMP29198.
Physicochemical Information
-
Formula
- C187H316N54O69S
Absent Amino Acids
- FHMPTWY
Common Amino Acids
- ILNS
Mass
- 4456.95
PI
- 4.2
Basic Residues
- 3
Acidic Residues
- 7
Hydrophobic Residues
- 15
Net Charge
- -4
-
Boman Index
- -7072
Hydrophobicity
- -0.16
Aliphatic Index
- 118.33
Half Life
-
- Mammalian:1.1 hour
- Yeast:3 min
- E.coli:>10 hour
Extinction Coefficient Cystines
- 0
Absorbance 280nm
- 0
Polar Residues
- 15
DRAMP29198
Comments Information
Mechanism of action
- The lipopeptide is derived from the C-terminal heptad repeat (HRC) domain of SARS-CoV-2 S that potently inhibits infection by SARS-CoV-2.
Literature Information
- ·Literature 1
-
Title
- Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.
-
Pubmed ID
- 33082259
-
Reference
- mBio. 2020 Oct 20;11(5):e01935-20.
-
Author
- Outlaw VK, Bovier FT, Mears MC, Cajimat MN, Zhu Y, Lin MJ, Addetia A, Lieberman NAP, Peddu V, Xie X, Shi PY, Greninger AL, Gellman SH, Bente DA, Moscona A, Porotto M.
- ·Literature 2
-
Title
- Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets.
-
Pubmed ID
- 33597220
-
Reference
- Science. 2021 Mar 26;371(6536):1379-1382.
-
Author
- de Vries RD, Schmitz KS, Bovier FT, Predella C, Khao J, Noack D, Haagmans BL, Herfst S, Stearns KN, Drew-Bear J, Biswas S, Rockx B, McGill G, Dorrello NV, Gellman SH, Alabi CA, de Swart RL, Moscona A, Porotto M.